1. Control Crohn Safe with episodic adalimumab monotherapy as first-line treatment study (CoCroS): study protocol for a randomised controlled trial. Issue 5 (4th May 2021) Authors: Janssen, Laura; Romberg-Camps, Mariëlle; van Bodegraven, Ad; Haans, Jeoffrey; Aquarius, Michèl; Boekema, Paul; Munnecom, Tamara; Brandts, Lloyd; Joore, Manuela; Masclee, Adrian; Jonkers, D; Pierik, M Journal: BMJ open Issue: Volume 11:Issue 5(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗